Web Watch

Share this article:
The online health space is hotter than high school love right now. The people at WebMD must be looking over their shoulder.

 Yahoo! Health and MSN Health are already attracting large audiences of health seekers and their early entry into the online health space has allowed them to establish themselves as a valuable resource for health information.

The HealthCentral Network recently expanded and now publishes 25 targeted media channels under the guidance of president  & CEO Chris Schroeder.

HealthFinder, MedlinePlus and Womenshealth.gov now offer an array of info in English as well as Spanish.

NBC Universal, parent company of iVillage, Healthology, and HealthCentersOnline, launched iVillage Total Health, a site that leverages all of NBC Universal's online and offline media assets which include regular segments on Today Show as well as iVillage live.

Waterfront Media launched Everydayhealth.com a site that offers advice from experts, health news, online check ups and other unique features.

Former AOL founder Steve Case has put together an impressive team to create Revolution Health. The preview site promises smarter health tools, more relevant information and expert support from live professionals. 

WebMD certainly isn't standing pat while all this activity swirls around them. Their acquisitions of Summex, a provider of health and wellness programs, and  Subimo, a company that specializes in healthcare decision support, suggests their strategy includes the emerging corporate wellness market.

Healthcare marketers are the likely benefactors of the health information portal expansion as targeted health ad inventory increases keeping prices at a reasonable level. There are likely to be some sponsorship opportunities as these portals find new ways to engage health info seekers.

Dan McKillen is president of the HealthDay news service

Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...